Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1
Dr. Megan Kruse and Dr. Hope Rugo discuss practice-changing data in metastatic breast cancer and critical shifts in the treatment of early-s...
Radio and PodcastLive Radio & PodcastsScience & Medicine
ASCO Daily News
The ASCO Daily News Podcast Series features oncologists discussing the latest research and therapies in their areas of expertise.
Episodes
20 of 114 episodesGU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPART
Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss high-impact abstracts in the treatment of prostate, bladder, and kidney cancers that...
Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers
Dr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and...
GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More
Dr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other novel treatment approaches that were p...
Hematologic Cancer Highlights From ASCO26: MajesTEC-9, frontMIND, and More
Dr. Marc Braunstein and Dr. Adam Kittai highlight top research on hematologic malignancies from the 2026 ASCO Annual Meeting, including stud...
Lung Cancer Highlights From ASCO26: HARMONi-6, LIBRETTO-436, and More
Dr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 2026 ASCO Annual Meeting, including k...
Day 5: Top Takeaways From ASCO26
Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mu...
Day 4: Top Takeaways From ASCO26
Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated study in hepatocellular carcinoma,...
Day 3: Top Takeaways From ASCO26
Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCR...
Day 2: Top Takeaways From ASCO26
Dr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, adv...
Day 1: Top Takeaways From ASCO26
In the first episode of a special daily series during the 2026 ASCO Annual Meeting, Dr. Monty Pal discusses 3 abstracts, including a follow-...
ASCO26 Preview: Novel Therapies and Innovations in Cancer Care
Dr. Monty Pal and Dr. Jo Chien preview new research, hot topics, and emerging innovations in oncology that will be presented at the 2026 ASC...
The Future of AI in Oncology: A Conversation With Google's AI Innovators
Google DeepMind's Dr. Alan Karthikesalingam and Google research scientist Anil Palepu sit down with Dr. Monty Pal to discuss the potential o...
'No Margin for Error': What to Know Before Implementing AI in Clinical Practice
Dr. Monty Pal and Dr. Arturo Loaiza-Bonilla discuss the institutional risks in the use of artificial intelligence (AI) in clinical practice...
Groundbreaking Results Shift Treatment Paradigm in High-Risk Smoldering Multiple Myeloma
Dr. Monty Pal speaks with internationally acclaimed hematologists Dr. Vincent Rajkumar and Dr. Saad Usmani about the AQUILA trial in high-ri...
Navigating Therapeutic Advances in EGFR-Mutated NSCLC
Dr. Monty Pal and Dr. Vamsi Velcheti discuss the evolving treatment landscape in EGFR-mutated non-small cell lung cancer, including landmark...
Highlights From the 2026 ASCO GU Cancers Symposium
Dr. Monty Pal and Dr. Andrea Apolo discuss practice-changing studies and other novel approaches in bladder, kidney, and prostate cancers tha...
Personalizing Treatment in Head and Neck Cancers
Dr. Monty Pal and Dr. Ari Rosenberg discuss the evolution of treatment strategies in head and neck cancers, including the challenges of trea...
Can Low-Dose Immunotherapy Expand Global Access to Cancer Care?
Dr. Monty Pal and Dr. Atul Batra discuss the PLANeT study from India, which evaluated low-dose pembrolizumab in addition to neoadjuvant chem...
Highlights From the 2026 ASCO GI Cancers Symposium
Dr. Monty Pal and Dr. Mary Feng discuss the latest advances in metastatic colorectal, gastric, and gastroesophageal cancers that were presen...